Effect of Regulatory Warnings on Antidepressant Prescribing for Children and Adolescents | Zendy

Benji T. Kurian | Zendy; Wayne A. Ray | Zendy; Patrick G. Arbogast | Zendy; D. Catherine Fuchs | Zendy; Judith A. Dudley | Zendy; William O. Cooper | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Regulatory Warnings on Antidepressant Prescribing for Children and Adolescents

Author(s) -

Benji T. Kurian,

Wayne A. Ray,

Patrick G. Arbogast,

D. Catherine Fuchs,

Judith A. Dudley,

William O. Cooper

Publication year - 2007

Publication title -

archives of pediatrics and adolescent medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3628

pISSN - 1072-4710

DOI - 10.1001/archpedi.161.7.690

Subject(s) - antidepressant , confidence interval , serotonin reuptake inhibitor , medicine , fluoxetine , medical prescription , reuptake inhibitor , psychiatry , paroxetine , serotonin , pharmacology , anxiety , receptor

To evaluate the effect of UK and US warnings placed in response to reports of suicidal thinking in pediatric patients receiving selective serotonin reuptake inhibitor and selective norepinephrine reuptake inhibitor antidepressants on antidepressant prescribing for children and adolescents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research